Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· January 8, 2026

Croissance organique de +6,0 % au premier trimestre 2026 - Confirmation des objectifs annuels

View original at globenewswire.com
Croissance organique de +6,0 % au premier trimestre 2026 - Confirmation des objectifs annuels Communiqué de presse Roubaix, 8 janvier 2026 Croissance organique de +6,0 % au premier trimestre 2026 Confirmation des objectifs annuels Chiffre d’affaires par segment de produits (en millions d'euros)2025 1er trimestre2026 1e…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Company is structured toward new target of €2 billion revenue

    80% confidence
  • Net revenue retention rate reached 105% on a comparable basis

    80% confidence
  • Q1 revenue exceeded €275 million with 6.0% organic growth

    80% confidence
  • OVHcloud confirms all FY2026 objectives including positive Free Cash-Flow generation

    80% confidence
  • Supply chain optimization initiated in 2025 allows continued service delivery while respecting investment envelope

    80% confidence
  • Group maintained operational and financial discipline, particularly on general and administrative expense control

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com